Outpatient Treatment of Low-Risk Venous Thromboembolism With Target Specific Anticoagulant

Trial Profile

Outpatient Treatment of Low-Risk Venous Thromboembolism With Target Specific Anticoagulant

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 21 Mar 2017

At a glance

  • Drugs Rivaroxaban (Primary) ; Warfarin
  • Indications Venous thromboembolism
  • Focus Therapeutic Use
  • Most Recent Events

    • 14 Mar 2017 Planned End Date changed from 1 Mar 2017 to 1 Mar 2020.
    • 14 Mar 2017 Planned primary completion date changed from 1 Mar 2016 to 1 Mar 2019.
    • 09 Mar 2016 Planned End Date changed from 1 Mar 2015 to 1 Mar 2017, as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top